Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Fusion Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 39 | 1 | 40 | +2 |
| Shares | 27.5M | 3.67M | 27.9M | +4.04M (+17.0%) |
| Value | $221.8M | $29.7M | $220.6M | +$28.5M (+14.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Johnson & Johnson | 3,670,516 | $29.1M | 2.55% |
| Sofinnova Investments, Inc. | 78,066 | $618.0K | 0.04% |
| Tekla Capital Management LLC | 43,394 | $344.0K | 0.01% |
| Sectoral Asset Management Inc | 38,198 | $303.0K | 0.03% |
| Millennium Management LLC | 26,925 | $213.0K | 0.00% |
| Cutler Group LP | 100 | $0 | 0.00% |
Sold out (4)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 75,000 | $606.0K |
| HRT Financial LP | 14,180 | $114.0K |
| Altfest L J & Co Inc | 10,213 | $83.0K |
| Paragon Wealth Strategies, LLC | 18 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29.7M |